Review article · 29 Jul 2022
Review articlePublished 22 Jul 2016
Potential future denervation targets
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The human sympathetic nervous system has an important regulatory role. In its dysfunctional hyperexcitatory state, it can lead to multiple pathologies. The renal sympathetic nerves play a significant role in these pathological states. Percutaneous renal sympathetic denervation (RSDN) allows for safe minimally invasive selective denervation of the renal sympathetic nerves. RSDN has been shown to be safe and efficacious in blood pressure reduction in earlier nonblinded SYMPLICITY HTN-1 and -2 trials. In Europe, it is approved for a select group of truly resistant severe essential hypertension. However, its real efficacy is now in doubt with the blinded SYMPLICITY HTN-3 trial that showed no significant difference in change in office and mean 24-h ambulatory systolic blood pressure between RSDN and sham-procedure arms. This review will look at the potential targets for percutaneous RSDN-heart failure, cardiac arrhythmias and kidney disease, sleep-disordered breathing and insulin resistance.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2013
Expanding the Targets of Renal Sympathetic Denervation: From Resistant Hypertension to Atrial Fibrillation
Review article · 21 Jul 2016
Renal sympathetic denervation: indications, contemporary devices and future directions
Short communication · 1 Sep 2025
Personalized Hypertension Management: Guidelines, Targets, Future
Rapid communication · 29 Nov 2024
Therapeutic Targeting of Angiogenesis in Atherosclerosis: Challenges and Future Directions
More from this journal
The newest in Interventional Cardiology.
Article · 27 May 2026
Commentary on Stent-Induced Coronary Stenosis in a Previously Noncritical Segment Following PCI: A Case Report
Article · 24 Mar 2026
Redo arteriovenous fistula in end stage kidney disease: Risk factors and outcomes in Taiz – Yemen
Article · 23 Feb 2026
The Silent Giant : Incidental Discovery of a Large Left Atrial Myxoma
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInterventional Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “KTG Leong”
- BylineArticles whose byline prints “A Walton”
- BylineArticles whose byline prints “H Krum & MP Schlaich”
